|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.15 TWD | -0.96% |
|
-3.60% | -5.49% |
BioGend Therapeutics Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 109.91 million compared to TWD 31.45 million a year ago. Net loss was TWD 156.33 million compared to TWD 184.46 million a year ago.
Basic loss per share from continuing operations was TWD 1.3 compared to TWD 1.79 a year ago. Diluted loss per share from continuing operations was TWD 1.3 compared to TWD 1.79 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.49% | 138M | |
| +54.05% | 58.71B | |
| -2.02% | 41.31B | |
| +37.01% | 39.2B | |
| -10.22% | 27.4B | |
| +13.42% | 26.55B | |
| -21.60% | 18.98B | |
| +2.89% | 12.51B | |
| +22.40% | 11.94B | |
| +27.49% | 12.08B |
BIOGEND THERAPEUTICS CO., LTD. 
